Steven H. Stein's most recent trade in Incyte Corp. was a trade of 12,714 Common Stock done at an average price of $68.2 . Disclosure was reported to the exchange on July 2, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Incyte | Steven H. Stein | EVP & Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 68.17 per share. | 02 Jul 2025 | 12,714 | 112,418 (0%) | 0% | 68.2 | 866,713 | Common Stock |
| Incyte | Steven H. Stein | EVP & Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2025 | 37,198 | 104,165 (0%) | 0% | 0 | Common Stock | |
| Incyte | Steven H. Stein | EVP & Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2025 | 20,967 | 125,132 (0%) | 0% | 0 | Common Stock | |
| Incyte | Steven H. Stein | EVP & Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 28,202 | 28,202 | - | - | Employee Stock Option (right to buy) | |
| Incyte | Steven H. Stein | EVP & Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 72.69 per share. | 17 Jan 2025 | 12,352 | 66,967 (0%) | 0% | 72.7 | 897,867 | Common Stock |
| Incyte | Steven H. Stein | EVP & Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 72.46 per share. | 15 Jan 2025 | 10,692 | 79,319 (0%) | 0% | 72.5 | 774,742 | Common Stock |
| Incyte | Steven H. Stein | EVP & Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 60.63 per share. | 12 Aug 2024 | 11,608 | 90,011 (0%) | 0% | 60.6 | 703,793 | Common Stock |
| Incyte | Steven H. Stein | EVP & Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2024 | 31,088 | 31,088 | - | - | Employee Stock Option (right to buy) | |
| Incyte | Steven H. Stein | EVP & Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2024 | 13,895 | 103,174 (0%) | 0% | 0 | Common Stock | |
| Incyte | Steven H. Stein | EVP & Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 64.25 per share. | 15 Jul 2024 | 1,555 | 101,619 (0%) | 0% | 64.3 | 99,909 | Common Stock |
| Incyte | Steven H. Stein | EVP & Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 59.02 per share. | 02 Jul 2024 | 8,316 | 89,279 (0%) | 0% | 59.0 | 490,810 | Common Stock |
| Repare Therapeutics Inc | Steven H. Stein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2024 | 54,000 | 54,000 | - | - | Stock Option (right to buy) | |
| Incyte | H. Steven Stein | EVP & Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 7,377 | 97,595 (0%) | 0% | 0 | Common Stock | |
| Incyte | Steven H. Stein | EVP & Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2024 | 30,580 | 30,580 | - | - | Employee Stock Option (right to buy) | |
| Incyte | Steven H. Stein | EVP & Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 65.51 per share. | 03 Jan 2024 | 7,365 | 90,218 (0%) | 0% | 65.5 | 482,481 | Common Stock |
| Incyte | Steven H. Stein | EVP & Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 63.28 per share. | 01 Aug 2023 | 21,511 | 97,583 (0%) | 0% | 63.3 | 1,361,216 | Common Stock |
| Incyte | Steven H. Stein | EVP & Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2023 | 28,385 | 28,385 | - | - | Employee Stock Option (right to buy) | |
| Incyte | Steven H. Stein | EVP & Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2023 | 13,535 | 119,094 (0%) | 0% | 0 | Common Stock | |
| Incyte | Steven H. Stein | EVP & Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 62.08 per share. | 03 Jul 2023 | 8,442 | 105,559 (0%) | 0% | 62.1 | 524,079 | Common Stock |
| Theseus Pharmaceuticals Inc | Steven H. Stein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2023 | 19,500 | 19,500 | - | - | Stock Option (right to buy) | |
| Theseus Pharmaceuticals Inc | Steven H. Stein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2023 | 3,250 | 3,250 | - | - | Restricted Stock Unit | |
| Incyte | Steven H. Stein | EVP & Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2023 | 27,096 | 27,096 | - | - | Employee Stock Option (right to buy) | |
| Incyte | Steven H. Stein | EVP & Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2023 | 4,980 | 114,001 (0%) | 0% | 0 | Common Stock | |
| Incyte | Steven H. Stein | EVP & Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 79.78 per share. | 04 Jan 2023 | 28,399 | 109,021 (0%) | 0% | 79.8 | 2,265,672 | Common Stock |
| Theseus Pharmaceuticals Inc | Steven H. Stein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Oct 2022 | 60,000 | 60,000 | - | - | Stock Option (right to buy) | |
| Incyte | Steven H. Stein | EVP & Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jul 2022 | 25,665 | 25,665 | - | - | Employee Stock Option (right to buy) | |
| Incyte | Steven H. Stein | EVP & Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jul 2022 | 18,941 | 141,276 (0%) | 0% | 0 | Common Stock | |
| Incyte | Steven H. Stein | EVP & Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 79.25 per share. | 02 Jul 2022 | 3,856 | 137,420 (0%) | 0% | 79.3 | 305,588 | Common Stock |
| Incyte | Steven H. Stein | EVP & Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 75.63 per share. | 28 Jun 2022 | 11,488 | 122,335 (0%) | 0% | 75.6 | 868,837 | Common Stock |
| Kura Oncology Inc | Steven H. Stein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2022 | 23,000 | 23,000 | - | - | Option to purchase common stock | |
| Incyte | Steven H. Stein | EVP & Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2022 | 15,054 | 15,054 | - | - | Employee Stock Option (right to buy) | |
| Incyte | Steven H. Stein | EVP & Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2022 | 28,926 | 133,823 (0%) | 0% | 0 | Common Stock | |
| Incyte | Steven H. Stein | EVP & Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2021 | 2,355 | 104,897 (0%) | 0% | 0 | Common Stock | |
| Incyte | Steven H. Stein | EVP & Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2021 | 379 | 102,542 (0%) | 0% | 0 | Common Stock | |
| Incyte | Steven H. Stein | EVP & Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jul 2021 | 15,054 | 15,054 | - | - | Employee Stock Option (right to buy) | |
| Incyte | Steven H. Stein | EVP & Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jul 2021 | 7,853 | 105,518 (0%) | 0% | 0 | Common Stock | |
| Incyte | Steven H. Stein | EVP & Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 83.58 per share. | 02 Jul 2021 | 2,953 | 102,565 (0%) | 0% | 83.6 | 246,812 | Common Stock |
| Incyte | Steven H. Stein | EVP & Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 83.34 per share. | 02 Jul 2021 | 402 | 102,163 (0%) | 0% | 83.3 | 33,503 | Common Stock |
| Incyte | Steven H. Stein | EVP & Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 85.61 per share. | 28 Jun 2021 | 22,079 | 97,665 (0%) | 0% | 85.6 | 1,890,183 | Common Stock |
| Kura Oncology Inc | Steven H. Stein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2021 | 23,000 | 23,000 | - | - | Option to purchase common stock | |
| Incyte | Steven H. Stein | EVP & Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 100.00 per share. | 25 Jan 2021 | 3,795 | 119,744 (0%) | 0% | 100 | 379,500 | Common Stock |
| Incyte | Steven H. Stein | EVP & Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jan 2021 | 3,795 | 8,539 | - | - | Non-Qualified Stock Option (right to buy) | |
| Incyte | Steven H. Stein | EVP & Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 68.62 per share. | 25 Jan 2021 | 3,795 | 123,539 (0%) | 0% | 68.6 | 260,413 | Common Stock |
| Incyte | Steven H. Stein | EVP & Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2021 | 23,044 | 119,744 (0%) | 0% | 0 | Common Stock | |
| Incyte | Steven H. Stein | EVP & Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2021 | 12,743 | 12,743 | - | - | Employee Stock Option (right to buy) | |
| Incyte | Steven H. Stein | EVP & Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Nov 2020 | 1,232 | 96,700 (0%) | 0% | 0 | Common Stock | |
| Incyte | Steven H. Stein | EVP & Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 103.83 per share. | 15 Jul 2020 | 766 | 95,468 (0%) | 0% | 103.8 | 79,534 | Common Stock |
| Incyte | Steven H. Stein | EVP & Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 104.25 per share. | 15 Jul 2020 | 623 | 96,234 (0%) | 0% | 104.3 | 64,948 | Common Stock |